切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2025, Vol. 11 ›› Issue (04) : 407 -411. doi: 10.3877/cma.j.issn.2096-1537.2025.04.012

综述

骆驼乳清蛋白在脓毒症辅助治疗中的应用前景
姜波1,2, 尤伟艳1, 薛庆1,2, 赵长甲1,2, 张琪1,2, 任珊1,()   
  1. 1 832008 石河子,石河子大学第一附属医院重症医学一科
    2 832000 石河子,石河子大学医学院
  • 收稿日期:2025-01-26 出版日期:2025-11-28
  • 通信作者: 任珊
  • 基金资助:
    兵团指导性科技计划项目(2023ZD020,2023ZD003); 石河子大学校级自主立项科研项目(ZZZC2022086)

The potential of camel whey as an adjuvant therapy for sepsis

Bo Jiang1,2, Weiyan You1, Qing Xue1,2, Changjia Zhao1,2, Qi Zhang1,2, Shan Ren1,()   

  1. 1 Department of Critical Care Medicine, the First Affiliated Hospital of Shihezi University, Shihezi 832008, China
    2 Shihezi University, Shihezi 832000, China
  • Received:2025-01-26 Published:2025-11-28
  • Corresponding author: Shan Ren
引用本文:

姜波, 尤伟艳, 薛庆, 赵长甲, 张琪, 任珊. 骆驼乳清蛋白在脓毒症辅助治疗中的应用前景[J/OL]. 中华重症医学电子杂志, 2025, 11(04): 407-411.

Bo Jiang, Weiyan You, Qing Xue, Changjia Zhao, Qi Zhang, Shan Ren. The potential of camel whey as an adjuvant therapy for sepsis[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2025, 11(04): 407-411.

骆驼乳清蛋白(CWP)是骆驼奶在加工过程中分离出来的蛋白质部分,在骆驼奶中的含量较高,是骆驼奶营养价值的重要组成部分,其蛋白质含量高,且易于被人体消化吸收,并以其纯度高、吸收率高、氨基酸组成最合理等诸多优势被推为“蛋白之王”,是公认的人体优质蛋白质补充剂之一。同时,已有相关研究发现其具有抗炎抑菌、抗病毒、抗氧化、免疫调节等多种生物活性功能,且致敏性低,这些生物活性功能在医学上表现出一定的治疗和预防疾病的潜力。本文根据现有研究,综述CWP的生物学活性功能对促进人体健康和疾病康复等临床应用价值,旨在为脓毒症的辅助治疗提供新方案,并为其在临床中的开发利用提供理论依据。

Camel whey protein (CWP), a by-product derived from camel milk during processing, is a nutritionally rich component characterized by its high protein content, excellent digestibility and efficient absorption. Recognized for its high purity,superior absorption rate, and well-balanced amino acid profile, CWP is often regarded as a"king of protein"and is acknowledged as a high-quality dietary protein supplements. Furthermore, emerging research has revealed that CWP possesses diverse bioactive properties, including anti-inflammatory, antimicrobial, antiviral, antioxidant, and immunomodulatory effects, alongside lowallergenicity. These bioactivities suggest considerable potential for CWP in the treatment and prevention of various diseases. This review summarizes the current evidence biological activities of CWP and its potential clinical applications in promoting health and facilitating recovery from disease, with a specific focus on proposing a novel adjuvant therapeutic strategy forsepsis. Our aim is to provide a theoretical foundation for the future clinical development and utilization of CWP.

1
Ho TM, Zou Z, Bansal N. Camel milk: a review of its nutritional value, heat stability, and potential food products [J]. Food Res Int, 2022, 153: 110870.
2
Mohamed H, Nagy P, Agbaba J, et al. Use of near and mid infra-red spectroscopy for analysis of protein, fat, lactose and total solids in raw cow and camel milk [J]. Food Chem, 2021, 334: 127436.
3
Zhao S, Pan F, Cai S, et al. Secrets behind protein sequences: unveiling the potential reasons for varying allergenicity caused by caseins from cows, goats, camels, and mares based on bioinformatics analyses [J]. Int J Mol Sci, 2023, 24(3): 2481.
4
El-Agamy E. Milk Allergy [A]//Fuquay JW, Fox PF, McSweeney PLH, et al. Encyclopedia of Dairy Science [M]. London: Elsevier Academic Press, 2011: 1041-1045.
5
Zhao D, Bai Y, Niu Y. Composition and characteristics of Chinese bactrian camel milk[J]. Small Ruminant Res, 2015, 127: 58-67.
6
Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference [J]. Intensive Care Med, 2003, 29(4):530-538.
7
Omar A, Harbourne N, Oruna-Concha MJ. Quantification of major camel milk proteins by capillary electrophoresis [J]. Int Dairy J, 2016, 58: 31-35.
8
田荣荣, 白沙沙, 徐佳佳, 等. 不同来源乳中α乳白蛋白、β乳球蛋白和乳铁蛋白含量分析 [J]. 食品工业科技, 2020, 41(4): 311-315.
9
Almehdar HA, Abd El-Baky N, Mattar EH, et al. Exploring the mechanisms by which camel lactoferrin can kill Salmonella enterica serovar typhimurium and Shigella sonnei [J]. PeerJ, 2023, 11: e14809.
10
Soleimani S, Zibaei S, Anvari M. Evaluation of the effect of lactoferricin obtained from lactoferrin on Staphylococcus aureus and Pseudomonas aeruginosa bacteria [J]. Biol J Microorganism, 2023, 13(1): 1-8.
11
王艳明, 妮尕热·阿布都外力, 迪娜热尔·迪力达西, 等. 驼乳源益生菌对db/db鼠肠道菌群的调节作用 [J]. 中国微生态学杂志, 2019, 31(12): 1365-1371.
12
Conner GE, Salathe M, Forteza R. Lactoperoxidase and hydrogen peroxide metabolism in the airway [J]. Am J Respir Crit Care Med, 2002, 166(12 Pt 2): S57-61.
13
Kussendrager KD, van Hooijdonk AC. Lactoperoxidase: physico-chemical properties, occurrence, mechanism of action and applications [J]. Br J Nutr, 2000, 84 (Suppl 1): S19-25.
14
Mehrin B, Saeid Z, Maryam I, et al. The extract of lactoperoxidase enzyme from camel milk using chromatography methods and its antibacterial effects on Pseudomonas Aeruginosa [J].Clinical Biochemistry, 2011, 44 (13 Suppl): S92.
15
李超颖, 张娟, 卿德刚, 等. 骆驼乳营养成分及生物活性研究进展 [J]. 食品工业科技, 2014, 35(23): 387-391, 396.
16
Badr G, Sayed LH, Omar H, et al. Camel whey protein protects B and T cells from apoptosis by suppressing activating transcription factor-3 (ATF-3)-mediated oxidative stress and enhancing phosphorylation of AKT and IκB-α in type Ⅰ diabetic mice [J]. Cell Physiol Biochem, 2017, 41(1): 41-54.
17
Al-Omari MM, Al-Ghariebeh RB, Alhaija AAA, et al. Camel milk whey inhibits inflammatory colorectal cancer development via down regulation of pro-inflammatory cytokines in induced AOM/DSS mouse model [J]. Emir J Food Agric, 2019, 31(4): 256-262.
18
el Agamy EI, Ruppanner R, Ismail A, et al. Antibacterial and antiviral activity of camel milk protective proteins [J]. J Dairy Res, 1992, 59(2): 169-175.
19
El-Fakharany EM, Abedelbaky N, Haroun BM, et al. Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatoma [J]. Virol J, 2012, 9: 201.
20
Esmail ME, Ashraf T, El WA, et al. Potential activity of camel milk-amylase and lactoferrin against hepatitis C virus infectivity in Hepg2 and lymphocytes [J]. Hepat Mon, 2008, 2008: 101-109.
21
Liao Y, El-Fakkarany E, Lönnerdal B, et al. Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7.5 cells [J]. J Med Microbiol, 2012, 61(Pt 3): 375-383.
22
Rasheed Z. Medicinal values of bioactive constituents of camel milk: a concise report [J]. Int J Health Sci (Qassim), 2017, 11(5): 1-2.
23
Legrand D, Pierce A, Elass E, et al. Lactoferrin structure and functions [A]//In Bioactive components of milk [M]. Springer, 2008: 163-194.
24
Redwan EM, El-Fakharany EM, Uversky VN, et al. Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus [J]. BMC Complement Altern Med, 2014, 14: 219.
25
Selinka HC, Giroglou T, Sapp M. Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions [J]. Virology, 2002, 299(2): 279-287.
26
Davies MJ, Hawkins CL, Pattison DI, et al. Mammalian heme peroxidases: from molecular mechanisms to health implications [J]. Antioxid Redox Signal, 2008, 10(7): 1199-1234.
27
Redwan EM, Almehdar HA, EL-Fakharany EM, et al.Potential antiviral activities of camel, bovine, and human lactoperoxidases against hepatitis C virus genotype 4 [J]. RSC Adv, 2015, 5(74): 60441-60452.
28
Courtois P, van Beers D, de Foor M, et al. Abolition of herpes simplex cytopathic effect after treatment with peroxidase generated hypothiocyanite [J]. J Biol Buccale, 1990, 18(2): 71-74.
29
Mikola H, Waris M, Tenovuo J. Inhibition of herpes simplex virus type 1, respiratory syncytial virus and echovirus type 11 by peroxidase-generated hypothiocyanite [J]. Antiviral Res, 1995, 26(2): 161-171.
30
Yamaguchi Y, Semmel M, Stanislawski L, et al. Virucidal effects of glucose oxidase and peroxidase or their protein conjugates on human immunodeficiency virus type 1 [J]. Antimicrob Agents Chemother, 1993, 37(1): 26-31.
31
Holt LJ, Herring C, Jespers LS, et al. Domain antibodies: proteins for therapy [J]. Trends Biotechnol, 2003, 21(11): 484-490.
32
Yang H, Villani RM, Wang H, et al. The role of cellular reactive oxygen species in cancer chemotherapy [J]. J Exp Clin Cancer Res, 2018, 37(1): 266.
33
Brieger K, Schiavone S, Miller FJ Jr, et al. Reactive oxygen species: from health to disease [J]. Swiss Med Wkly, 2012, 142: w13659.
34
Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state [J]. Nutr J, 2016, 15(1): 71.
35
Habib HM, Ibrahim WH, Schneider-Stock R, et al. Camel milk lactoferrin reduces the proliferation of colorectal cancer cells and exerts antioxidant and DNA damage inhibitory activities [J]. Food Chem, 2013, 141(1): 148-152.
36
Gauthier SF, Pouliot Y, Saint-Sauveur D. Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins [J]. Int Dairy J, 2006, 16(11): 1315-1323.
37
Badr G. Supplementation with undenatured whey protein during diabetes mellitus improves the healing and closure of diabetic wounds through the rescue of functional long-lived wound macrophages [J]. Cell Physiol Biochem, 2012, 29(3-4): 571-582.
38
Badr G, Mohany M, Metwalli A. Effects of undenatured whey protein supplementation on CXCL12- and CCL21-mediated B and T cell chemotaxis in diabetic mice [J]. Lipids Health Dis, 2011, 10: 203.
39
Ebaid H. Promotion of immune and glycaemic functions in streptozotocin-induced diabetic rats treated with un-denatured camel milk whey proteins [J]. Nutr Metab (Lond), 2014, 11: 31.
40
Ebaid H, Ahmed OM, Mahmoud AM, et al. Limiting prolonged inflammation during proliferation and remodeling phases of wound healing in streptozotocin-induced diabetic rats supplemented with camel undenatured whey protein [J]. BMC Immunol, 2013, 14: 31.
41
Ebaid H, Salem A, Sayed A, et al. Whey protein enhances normal inflammatory responses during cutaneous wound healing in diabetic rats [J]. Lipids Health Dis, 2011, 10: 235.
42
Walzem RL, Dillard CJ, German JB. Whey components: millennia of evolution create functionalities for mammalian nutrition: what we know and what we may be overlooking [J]. Crit Rev Food Sci Nutr, 2002, 42(4): 353-375.
43
Ebaid H, Badr G, Metwalli A, et al. Immunoenhancing property of dietary un-denatured whey protein derived from three camel breeds in mice [J]. Biologia, 2012, 67(2): 425-433.
44
Abdel Galil MAG, Abdulqader AA. The unique medicinal properties of camel products: a review of the scientific evidence [J]. Sci Evid, 2016, 11(2): 98-103.
45
Daley-Bauer LP, Purdy SR, Smith MC, et al. Contributions of conventional and heavy-chain IgG to immunity in fetal, neonatal, and adult alpacas [J]. Clin Vaccine Immunol, 2010, 17(12): 2007-2015.
46
Gizachew A, Teha J, Birhanu T, et al. Review on medicinal and nutritional values of camel milk [J]. Nat Sci, 2014, 12(12): 35-41.
47
Shamsia S. Nutritional and therapeutic properties of camel and human milks [J]. Int J Genet Mol Biol, 2009, 1(4): 52-58.
48
Haddadin MS, Gammoh SI, Robinson RK. Seasonal variations in the chemical composition of camel milk in Jordan [J]. J Dairy Res, 2008, 75(1): 8-12.
49
Zou Z, Duley JA, Cowley DM, et al. Comprehensive biochemical and proteomic characterization of seasonal Australian camel milk [J]. Food Chem, 2022, 381: 132297.
[1] 熊梓宏, 孙超, 张宁, 卢宾, 向玺, 罗小丽, 张国英. 脓毒症相关性脑病患儿颅内压增高风险预测的列线图模型构建与验证[J/OL]. 中华危重症医学杂志(电子版), 2025, 18(06): 447-455.
[2] 刘林峰, 张钱平, 卢春兴, 冯波, 陈奔, 张闻岩, 江雅婷, 沈辰曦, 陈灵涛, 高志鹏, 郝钰, 龚裕强. 血尿素氮轨迹与脓毒症患者28 d病死率的相关性:一项分组轨迹分析研究[J/OL]. 中华危重症医学杂志(电子版), 2025, 18(06): 456-462.
[3] 何林霞, 相阳, 刘心如, 郑兴锋. 巨噬细胞代谢重编程在脓毒症急性肺损伤中作用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(01): 69-74.
[4] 张巍, 邵明亮, 孙建华, 戴世荣, 吴金娜. 结肠癌脓毒症患者外周血单个核细胞整合素αL甲基化特征[J/OL]. 中华实验和临床感染病杂志(电子版), 2025, 19(05): 271-278.
[5] 钱何布, 朱林, 姚月平, 姚峰, 李玉卓, 马家驹, 晏倩, 倪晓艳. 应用机器学习建立脓毒性休克患者住院28天死亡预测模型及验证[J/OL]. 中华实验和临床感染病杂志(电子版), 2025, 19(05): 288-297.
[6] 陈林欣, 沈利汉, 邱敏珊, 卢瑞瑜, 赖燕波, 杜瑞冬, 卢敏贞, 王洁. RDW/PLT联合LODS评分预测脓毒症并发肺炎预后的临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(01): 89-94.
[7] 徐倩, 魏凤香. 干细胞:开启精神疾病治疗的新曙光[J/OL]. 中华细胞与干细胞杂志(电子版), 2026, 16(01): 52-55.
[8] 张婷, 张延美, 范皎, 卜玉, 张莉. 负载R848疏水性介孔二氧化硅纳米粒的制备及复极化巨噬细胞的研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2025, 15(06): 339-345.
[9] 安嘉伟, 刘国臣, 朱俊宇, 盖新宇. 细胞焦亡在脓毒症相关肝损伤中的作用机制及干预药物的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2025, 15(06): 374-382.
[10] 刘铁鑫, 王震侠. 肿瘤相关成纤维细胞在胰腺导管腺癌中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 124-131.
[11] 林水荣, 宋子敏, 于玺, 李绍强, 华赟鹏, 沈顺利. 术前抗病毒治疗对HBV相关肝癌肝切除术后肝衰竭影响[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(05): 700-706.
[12] 周懿, 黄容华, 刘政疆. 5-羟色胺与铁死亡介导的脓毒症心肌病的研究进展[J/OL]. 中华临床医师杂志(电子版), 2025, 19(08): 612-617.
[13] 宁雯琪, 张永利. 脓毒症心肌病的研究进展:基础、临床与展望[J/OL]. 中华临床医师杂志(电子版), 2025, 19(06): 461-466.
[14] 刘鑫, 王文惠, 吴守振. 脓毒症相关急性胃肠损伤患者I-FABP、D-乳酸及炎症因子变化及意义[J/OL]. 中华卫生应急电子杂志, 2025, 11(06): 351-355.
[15] 刘文倩, 王伊龙. 颅骨骨髓在中枢神经系统中的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(01): 9-15.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?